- Home
- AIZ vs BMRN Comparison
AIZ vs BMRN Comparison
Compare AIZ & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AIZ | BMRN |
|---|---|---|
| Founded | 1892 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.4B | 10.5B |
| IPO Year | N/A | 1999 |
Fundamental Metrics
Financial Performance| Metric | AIZ | BMRN |
|---|---|---|
| Price | $222.33 | $53.19 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 19 |
| Target Price | ★ $249.17 | $88.42 |
| AVG Volume (30 Days) | 276.7K | ★ 3.0M |
| Earning Date | 11-04-2025 | 10-27-2025 |
| Dividend Yield | ★ 1.58% | N/A |
| EPS Growth | 17.21 | ★ 59.53 |
| EPS | ★ 16.41 | 2.68 |
| Revenue | ★ $12,568,700,000.00 | $3,094,001,000.00 |
| Revenue This Year | $8.50 | $13.39 |
| Revenue Next Year | $5.73 | $7.57 |
| P/E Ratio | ★ $13.58 | $19.92 |
| Revenue Growth | 6.92 | ★ 12.39 |
| 52 Week Low | $174.97 | $50.76 |
| 52 Week High | $232.02 | $73.51 |
Technical Indicators
Market Signals| Indicator | AIZ | BMRN |
|---|---|---|
| Relative Strength Index (RSI) | 50.45 | 46.19 |
| Support Level | $219.53 | $53.03 |
| Resistance Level | $224.89 | $54.66 |
| Average True Range (ATR) | 3.67 | 1.45 |
| MACD | -0.87 | -0.11 |
| Stochastic Oscillator | 30.57 | 31.61 |
Price Performance
Historical ComparisonAbout AIZ Assurant Inc.
Assurant Inc is a protection company that partners with the brands to safeguard and service connected devices, homes and automobiles. It operate in North America, Latin America, Europe and Asia Pacific through two operating segments: Global Lifestyle and Global Housing. Global Lifestyle: includes mobile device solutions (including extended service contracts, insurance policies and related services), extended service contracts and related services for consumer electronics and appliances, and financial services and other insurance products. Global Housing: includes lender-placed homeowners, manufactured housing and flood insurance, as well as voluntary manufactured housing, condominium and homeowners insurance. Key revenue is generated from Global Lifestyle segment.
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.